Evidence map›Paper›PMID 40832318›Full record

ArticlebioRxiv : the preprint server for biology2025

Unmasking Pathogen Traits for Chronic Colonization in Neurogenic Bladder Patients.

Seth A Reasoner, Brendan T Frainey, Owen F Hale, Alexandra Borden, M Kyle Graham, Elise Turner, Lucas R Brenes, Carl B W Soderstrom, Hamilton Green, Jonathan E Schmitz and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Seth A ReasonerDivision of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-7791-1641
Brendan T FraineyDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-0371-7122
Owen F HaleDepartment of Biological Sciences, Vanderbilt University, Nashville, TN.ORCID 0000-0003-3895-1357
Alexandra BordenDivision of Healthcare of Women and Children, School of Nursing, Duke University, Durham, NC.
M Kyle GrahamDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0001-7664-6703
Elise TurnerDivision of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN.
Lucas R BrenesDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA.
Carl B W SoderstromDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA.
Hamilton GreenDivision of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN.
Jonathan E SchmitzDivision of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0002-2727-9078
Michael T LaubDepartment of Biology, Massachusetts Institute of Technology, Cambridge, MA.ORCID 0000-0002-8288-7607
Maryellen S KellyDivision of Healthcare of Women and Children, School of Nursing, Duke University, Durham, NC.ORCID 0000-0001-7733-8569
Douglass B ClaytonDepartment of Urology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-4460-4167
Maria HadjifrangiskouDivision of Molecular Pathogenesis, Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, TN.ORCID 0000-0003-4249-8997

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Medical Scientist Training ProgramT32GM152284 · NIGMS · VANDERBILT UNIVERSITY · PI Christopher S. Williams · 2024 to 2026
$4.8M
How E. coli Acid Response Mechanisms Breach Colonization Resistance in the VaginaR01AI168468 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Maria Hadjifrangiskou · 2022 to 2026
$2.9M
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical DiscoveryP20DK123967 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HADJIFRANGISKOU, MARIA · 2019 to 2020
$680k
Copper Sensing in Uropathogenic Escherichia coliF30AI169748 · NIAID · VANDERBILT UNIVERSITY · PI Seth A Reasoner · 2023 to 2026
$156k
NCATS NIH HHS UL1 TR002243NIAID NIH HHS F30 AI169748NIAID NIH HHS R01 AI168468NIDDK NIH HHS P20 DK123967NIGMS NIH HHS T32 GM007347NIGMS NIH HHS T32 GM152284
6 · The paper itself

Abstract

Individuals with neurogenic bladder are particularly susceptible to both chronic bacterial colonization of the bladder and urinary tract infections (UTIs). Neurogenic bladder can arise from a variety of diseases such as diabetes, spinal cord injuries, and spina bifida. To study the ecological and evolutionary dynamics of the microbiome in neurogenic bladder, we developed a longitudinal cohort of 77 children and young adults with spina bifida from two medical centers. We used enhanced urine culture, 16S rRNA sequencing, and whole genome sequencing to characterize the microbial composition of urine and fecal samples. In addition to prospective sample collection, we retrieved prior bacterial isolates from enrolled patients from Vanderbilt's clinical microbial biobank, MicroVU. This allowed us to compare bacterial isolates from the same patients over a period of five years. Urine samples were characterized by high abundance of urinary pathogens, such as

Indexed as

bacterial evolutionspina bifidaurinary microbiomeurinary tract infectionUrobiome

Identifiers

PMID40832318
PMCPMC12363967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.